Quality of IBD Care
National KPIs tracking Biological Therapies
Clinical KPIs for IBD
The Registry has developed and maintains the KPIs for the National Audit of Biological Therapies (now part of Quality Accounts).
These clinical KPIs track the improvement in biologics treatment of patients.
The Statement of Purpose, Scope and Requirements is here.
The clinical KPIs are detailed in this guide here.
We are now working with the BSG IBD section in reviewing an extension to these clinical KPIs, potentially to include capturing other key treatments such as steroid use in patients.
Diagram: the six clinical KPIs for monitoring quality of care in treatment using biological therapy (see Guide for details).
Reports and Publications
The following reports and papers are related to the biological therapies KPIs
Audit of Biological Therapy for inflammatory bowel disease (Gut, 1 June 2019).
Annual report on biological therapy 2019 (Registry annual report, 2019).
From IBD Audit to IBD Registry
In 2016 the national IBD audit came to an end, and the IBD Registry became the vehicle for the biological therapies audit and quality improvement programme.
The 2018 RCP IBD Audit Programme Review is here
Dr Ian Arnott, RCP Clinical Lead reflects in 2017 on 10 years of the RCP IBD Audit in Framing the Future